Cargando…

Heart Rate as a Marker of Relapse During Withdrawal of Therapy in Recovered Dilated Cardiomyopathy

OBJECTIVES: The objective of this study was to determine the relationship between heart rate and relapse among patients in the TRED-HF (Therapy withdrawal in REcovered Dilated cardiomyopathy trial). BACKGROUND: Understanding markers and mechanisms of relapse among patients with recovered dilated car...

Descripción completa

Detalles Bibliográficos
Autores principales:	Halliday, Brian P., Vazir, Ali, Owen, Ruth, Gregson, John, Wassall, Rebecca, Lota, Amrit S., Khalique, Zohya, Tayal, Upasana, Jones, Richard E., Hammersley, Daniel, Pantazis, Antonis, Baksi, A. John, Rosen, Stuart, Pennell, Dudley J., Cowie, Martin R., Cleland, John G.F., Prasad, Sanjay K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259664/ https://www.ncbi.nlm.nih.gov/pubmed/34119469 http://dx.doi.org/10.1016/j.jchf.2021.03.010

Ejemplares similares

Changes in clinical and imaging variables during withdrawal of heart failure therapy in recovered dilated cardiomyopathy
por: Halliday, Brian P., et al.
Publicado: (2022)

Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial
por: Halliday, Brian P, et al.
Publicado: (2019)

The addition of genetic testing and cardiovascular magnetic resonance to routine clinical data for stratification of etiology in dilated cardiomyopathy
por: Amin, Ravi J., et al.
Publicado: (2022)

Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction
por: Halliday, Brian P., et al.
Publicado: (2017)

Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium Enhancement
por: Halliday, Brian P., et al.
Publicado: (2019)

Direct and indirect effect of the COVID-19 pandemic on patients with cardiomyopathy
por: Hammersley, Daniel J, et al.
Publicado: (2022)

Genetic Architecture of Acute Myocarditis and the Overlap With Inherited Cardiomyopathy
por: Lota, Amrit S., et al.
Publicado: (2022)

Moderate excess alcohol consumption and adverse cardiac remodelling in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2022)

Sex‐ and age‐based differences in the natural history and outcome of dilated cardiomyopathy
por: Halliday, Brian P., et al.
Publicado: (2018)

Prognostic Significance of Nonischemic Myocardial Fibrosis in Patients With Normal LV Volumes and Ejection-Fraction
por: Lota, Amrit S., et al.
Publicado: (2021)

Exposure to Elevated Nitrogen Dioxide Concentrations and Cardiac Remodeling in Patients With Dilated Cardiomyopathy
por: Fecht, DANIELA, et al.
Publicado: (2022)

Phenotype and Clinical Outcomes of Titin Cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2017)

Randomized controlled trials of iron chelators for the treatment of cardiac siderosis in thalassaemia major
por: Baksi, A. John, et al.
Publicado: (2014)

Diffusion tensor cardiovascular magnetic resonance in hypertrophic cardiomyopathy: a comparison of motion-compensated spin echo and stimulated echo techniques
por: Khalique, Zohya, et al.
Publicado: (2019)

Association of Titin-Truncating Genetic Variants With Life-threatening Cardiac Arrhythmias in Patients With Dilated Cardiomyopathy and Implanted Defibrillators
por: Corden, Ben, et al.
Publicado: (2019)

Advanced 3D analysis of fibrotic ring-like pattern in non-ischemic cardiomyopathy predicts major arrhythmic events
por: Zaidi, H, et al.
Publicado: (2023)

Fibrosis entropy is associated with life-threatening arrhythmia in non-ischaemic cardiomyopathy
por: Zaidi, H, et al.
Publicado: (2023)

Comprehensive Phenotypic Characterization of Late Gadolinium Enhancement Predicts Sudden Cardiac Death in Coronary Artery Disease
por: Jones, Richard E., et al.
Publicado: (2023)

Evaluation of CMR predictors of right ventricular remodelling in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2016)

Evaluating the significance of left ventricular midwall fibrosis detected by late gadolinium enhancement imaging on left ventricular functional remodelling in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2016)

In-vivo cardiac DTI: An initial comparison of M012 compensated spin-echo and STEAM
por: Scott, Andrew D, et al.
Publicado: (2016)

An in-vivo comparison of stimulated-echo and motion compensated spin-echo sequences for 3 T diffusion tensor cardiovascular magnetic resonance at multiple cardiac phases
por: Scott, Andrew D., et al.
Publicado: (2018)

A qualitative exploration of participant and investigator perspectives from the TRED‐HF trial
por: Papageorgiou, Vasiliki, et al.
Publicado: (2021)

Precision Phenotyping of Dilated Cardiomyopathy Using Multidimensional Data
por: Tayal, Upasana, et al.
Publicado: (2022)

Iatrogenic myocarditis—biomarkers, cardiovascular MRI and the need for early diagnosis
por: Lota, Amrit S, et al.
Publicado: (2018)

Maintaining Success for Patients With Dilated Cardiomyopathy and Remission of Heart Failure
por: Halliday, Brian P., et al.
Publicado: (2022)

Accelerating Cardiac Diffusion Tensor Imaging With a U‐Net Based Model: Toward Single Breath‐Hold
por: Ferreira, Pedro F., et al.
Publicado: (2022)

Decongestion: Diuretics and other therapies for hospitalized heart failure
por: Vazir, Ali, et al.
Publicado: (2016)

The feasibility of a novel limited field of view spiral cine DENSE sequence to assess myocardial strain in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2019)

Review of Journal of Cardiovascular Magnetic Resonance 2012
por: Pennell, Dudley J, et al.
Publicado: (2013)

Review of Journal of Cardiovascular Magnetic Resonance 2013
por: Pennell, Dudley John, et al.
Publicado: (2014)

Osteoprotegerin and Myocardial Fibrosis in Patients with Aortic Stenosis
por: Loudon, Brodie L., et al.
Publicado: (2018)

Cardiac magnetic resonance perfusion imaging and the effects of single intravenous cannulation with the Octopus bionector
por: Kindler, Heiko E, et al.
Publicado: (2013)

Performance of artificial intelligence for biventricular cardiovascular magnetic resonance volumetric analysis in the clinical setting
por: Hatipoglu, Suzan, et al.
Publicado: (2022)

Myocardial remodelling and recovery in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2017)

The COVID-19 pandemic and heart failure: lessons from GUIDE-HF( )
por: Cowie, Martin R, et al.
Publicado: (2022)

Late-Gadolinium Enhancement Interface Area and Electrophysiological Simulations Predict Arrhythmic Events in Patients With Nonischemic Dilated Cardiomyopathy
por: Balaban, Gabriel, et al.
Publicado: (2021)

Comparison of white blood and black blood T2* cardiovascular magnetic resonance at 3 Tesla
por: Alam, Mohammed H, et al.
Publicado: (2014)

Myocardial iron assessment by T2* cardiovascular magnetic resonance at 3 Tesla
por: Alam, Mohammed H, et al.
Publicado: (2014)

Phenotypic Expression and Outcomes in Individuals With Rare Genetic Variants of Hypertrophic Cardiomyopathy
por: de Marvao, Antonio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o2d5ihccvm3bbgom207ln9j7gs